Investor pays SEK2.3bn for Aleris equity
publication date: Jul 7, 2010
The equity in Scandinavian healthcare, care and diagnostics group Aleris has been sold for SEK2.3bn, with a total price, including debt, of SEK4.4bn, to Investor AB. Aleris sales came to SEK3.9bn in 2009 with EBITDA at 11% or circa SEK430m. What are Investor's plans?
To get full access to this article you will need to subscribe to Healthcare Europa. This gives you indepth quality coverage of how the dynamic private healthcare sector is developing across Europe.
Please click here to look at subscription options.
You can, however, register for free to recieve limited access. This gives you access to headlines and the first lines of stories and you can ask us to send you a news email with headlines 40 times a year. As a free registrant, you can also view our blog. Click here to sign up for limited access free registration.